These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8589150)

  • 1. Predictors and outcome of multidrug-resistant tuberculosis.
    Salomon N; Perlman DC; Friedmann P; Buchstein S; Kreiswirth BN; Mildvan D
    Clin Infect Dis; 1995 Nov; 21(5):1245-52. PubMed ID: 8589150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved outcomes for patients with multidrug-resistant tuberculosis.
    Turett GS; Telzak EE; Torian LV; Blum S; Alland D; Weisfuse I; Fazal BA
    Clin Infect Dis; 1995 Nov; 21(5):1238-44. PubMed ID: 8589149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Health.
    Telzak EE; Chirgwin KD; Nelson ET; Matts JP; Sepkowitz KA; Benson CA; Perlman DC; El-Sadr WM
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):337-43. PubMed ID: 10206505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of defervescence in response to anti-tuberculosis therapy in patients with extrapulmonary tuberculosis and advanced human immunodeficiency virus infection.
    Hsieh SM; Sheng WH; Chen MY; Hung CC; Chang SC
    J Formos Med Assoc; 1999 Aug; 98(8):550-5. PubMed ID: 10502908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-resistant tuberculosis in human immunodeficiency virus infected persons in Italy. The Italian Drug-Resistant Tuberculosis Study Group.
    Angarano G; Carbonara S; Costa D; Gori A
    Int J Tuberc Lung Dis; 1998 Apr; 2(4):303-11. PubMed ID: 9559401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of multidrug-resistant tuberculosis treatment with early initiation of antiretroviral therapy for HIV co-infected patients in Lesotho.
    Satti H; McLaughlin MM; Hedt-Gauthier B; Atwood SS; Omotayo DB; Ntlamelle L; Seung KJ
    PLoS One; 2012; 7(10):e46943. PubMed ID: 23115633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
    Mannheimer SB; Sepkowitz KA; Stoeckle M; Friedman CR; Hafner A; Riley LW
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):319-25. PubMed ID: 9432387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South Africa.
    Brust JCM; Shah NS; Mlisana K; Moodley P; Allana S; Campbell A; Johnson BA; Master I; Mthiyane T; Lachman S; Larkan LM; Ning Y; Malik A; Smith JP; Gandhi NR
    Clin Infect Dis; 2018 Apr; 66(8):1246-1253. PubMed ID: 29293906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy.
    Sungkanuparph S; Eampokalap B; Chottanapund S; Bed ST; Manosuthi W
    J Med Assoc Thai; 2007 May; 90(5):884-8. PubMed ID: 17596041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pericarditis due to multidrug resistant Mycobacterium tuberculosis in an HIV infected patient: case report and review of literature].
    Lasso B M; Pérez G J
    Rev Chilena Infectol; 2009 Apr; 26(2):156-61. PubMed ID: 19621148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphism in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosis.
    Post FA; Willcox PA; Mathema B; Steyn LM; Shean K; Ramaswamy SV; Graviss EA; Shashkina E; Kreiswirth BN; Kaplan G
    J Infect Dis; 2004 Jul; 190(1):99-106. PubMed ID: 15195248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Survival time and influencing factors in multidrug-resistant tuberculosis patients in Wuhan, 2006-2014].
    Wang JJ; Zhou ML; Chen C; Wu G; Zuo YP; Ren X; Chen Z; Wang WH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1409-1413. PubMed ID: 31838813
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.
    Palacios E; Franke M; Muñoz M; Hurtado R; Dallman R; Chalco K; Guerra D; Mestanza L; Llaro K; Bonilla C; Sebastian J; Bayona J; Lygizos M; Anger H; Shin S
    Int J Tuberc Lung Dis; 2012; 16(3):348-54. PubMed ID: 22640448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death.
    Velásquez GE; Becerra MC; Gelmanova IY; Pasechnikov AD; Yedilbayev A; Shin SS; Andreev YG; Yanova G; Atwood SS; Mitnick CD; Franke MF; Rich ML; Keshavjee S
    Clin Infect Dis; 2014 Jul; 59(1):9-15. PubMed ID: 24729493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of fluoroquinolone-resistant tuberculosis in New York City.
    Sullivan EA; Kreiswirth BN; Palumbo L; Kapur V; Musser JM; Ebrahimzadeh A; Frieden TR
    Lancet; 1995 May; 345(8958):1148-50. PubMed ID: 7723548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
    Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
    J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
    Shibabaw A; Gelaw B; Wang SH; Tessema B
    PLoS One; 2018; 13(6):e0198080. PubMed ID: 29944658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of acquired MDR-TB and HIV co-infection.
    Deivanayagam CN; Rajasekaran S; Venkatesan R; Mahilmaran A; Ahmed PR; Annadurai S; Kumar S; Chandrasekar C; Ravichandran N; Pencillaiah R
    Indian J Chest Dis Allied Sci; 2002; 44(4):237-42. PubMed ID: 12437236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina.
    Palmero DJ; Ambroggi M; Brea A; De Lucas M; Fulgenzi A; Martínez D; Mosca C; Musella R; Natiello M; Gonzalez C; Abbate E
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):778-84. PubMed ID: 15182150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.